Glucose Bufus, 400 mg/ml 10 pcs 10 pcs

Glucose enhances redox processes in the body, improves the antitoxic function of the liver, covers part of the energy expenditure of the body, as it is a source of easily digestible carbohydrates. On entering the tissues it is phosphorylated and converted to glucose-6-phosphate that is actively involved in many parts of the body’s metabolism.

The 400 mg/ml solution is hypertonic. When the hypertonic solution is injected into the vein, the osmotic pressure of the blood increases, the contractile activity of the heart muscle increases, blood vessels dilate, the detoxification function of the liver improves and diuresis increases.

Pharmacokinetics

It is completely absorbed by the body, is not excreted by the kidneys (appearance in the urine is a pathological sign).

Indications

Hypoglycemia, carbohydrate deficiency, toxic infection, intoxication in liver diseases (hepatitis, liver dystrophy and atrophy, including liver failure), hemorrhagic diathesis; intoxication; collapse, shock.

Pharmacological effect

Glucose enhances redox processes in the body, improves the antitoxic function of the liver, and covers part of the body’s energy costs, as it is a source of easily digestible carbohydrates. Entering the tissues, it is phosphorylated, turning into glucose-6-phosphate, which is actively involved in many parts of the body’s metabolism.

A solution of 400 mg/ml is hypertonic. When a hypertonic solution is injected into a vein, the osmotic pressure of the blood increases, the contractile activity of the heart muscle increases, blood vessels dilate, the detoxification function of the liver improves, and diuresis increases.

Pharmacokinetics

It is completely absorbed by the body and is not excreted by the kidneys (appearance in urine is a pathological sign).

Special instructions

Glucose solution should not be administered quickly or for a long time.

Active ingredient

Dextrose

Composition

Dextrose monohydrate (in terms of dry matter dextrose) – 400 mg

Contraindications

Hypersensitivity, hyperglycemia, hyperlacticacidemia, hyperhydration, postoperative disorders of glucose utilization; circulatory disorders that threaten cerebral and pulmonary edema; cerebral edema, pulmonary edema, acute left ventricular failure, hyperosmolar coma, childhood.

With caution

Decompensated chronic heart failure, chronic renal failure (oligo-, anuria), hyponatremia, diabetes mellitus.

Side Effects

Ion balance disorders, hyperglycemia, glucosuria, fever, hypervolimia, acute left ventricular failure.

At the injection site – development of infection, thrombophlebitis.

Interaction

When combined with other drugs, it is necessary to visually monitor compatibility (invisible pharmaceutical or pharmacodynamic incompatibility is possible).

Overdose

Symptoms: hyperglycemia, glycosuria, hyperglycemic hyperosmolar coma, hyperhydration, water-electrolyte imbalance.

Treatment: stop administering glucose, administer insulin, symptomatic therapy.

Storage conditions

At temperatures from 5 to 30 °C.

Keep out of the reach of children.

Shelf life

3 years.

Manufacturer

Update of PFC JSC, Russia